Multicystic kidney disease: A complication of crizotinib

Diagnostic and Interventional Imaging

Volumn 96, Issue 4, 2015, Pages 393-395

  Souteyrand, P ^a,b   Burtey, S ^a,c   Barlesi, F ^d  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE MARSEILLE   (France)

^b Aix Marseille University   (France)

^c AIX MARSEILLE UNIVERSITY   (France)

^d University of the Mediterranean Aix Marseille II   (France)

Author keywords

Chemotherapy; Cyst; Iatrogenic; Kidney

Indexed keywords

CRIZOTINIB; PROTEIN KINASE INHIBITOR; PYRAZOLE DERIVATIVE; PYRIDINE DERIVATIVE;

CLINICAL OBSERVATION; COMPUTER ASSISTED TOMOGRAPHY; ECHOGRAPHY; FOLLOW UP; HUMAN; KIDNEY CYST; LETTER; MULTICYSTIC DYSPLASTIC KIDNEY; ULTRASOUND; CHEMICALLY INDUCED; RADIOGRAPHY;

HUMANS; MULTICYSTIC DYSPLASTIC KIDNEY; PROTEIN KINASE INHIBITORS; PYRAZOLES; PYRIDINES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84945561710     PISSN: None     EISSN: 22115684     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Brosnan EM, Weickhardt AJ, Lu X, Maxon DA, Barón AE, Chon-chol M, et al. Drug-induced reduction in estimated glomerularfiltration rate in patients with ALK-positive non-small cell lungcancer treated with the ALK inhibitor crizotinib. Cancer 2013, http://dx. doi. org/10. 1002/cncr. 28478.
2. Gastaud L, Ambrosetti D, Otto J, Marquette CH, Coutts M, Hofman P, et al. Acute kidney injury following crizotinibadministration for non-small-cell lung carcinoma. Lung Can-cer 2013;82(2):362-4, http://dx. doi. org/10. 1016/j. lungcan. 2013. 08. 007.
3. Qin S, Taglienti M, Nauli SM, Contrino L, Takakura A, Zhou J, et al. Failure to ubiquitinate c-MET leads to hyperactivationof mTOR signaling in a mouse model of autosomal dominantpolycystic kidney disease. J Clin Invest 2010;120(10):3617-28, http://dx. doi.org/10.1172/JCI41531 [Epub 2010 Sep 13].
4. Zhou D, Tan RJ, Lin L, Zhou L, Liu Y. Activation of hep-atocyte growth factor receptor, c-MET, in renal tubules isrequired for renoprotection after acute kidney injury. KidneyInt 2013;84(3):509-20, http://dx. doi. org/10. 1038/ki. 2013. 102[Epub 2013 May 29].
5. Prat M, Crepaldi T, Pennacchietti S, Bussolino F, Comoglio PM. Agonistic monoclonal antibodies against the Met receptor dis-sect the biological responses to HGF. J Cell Sci 1998;111(Pt2):237-47.